Tested Applications
| Positive WB detected in | HeLa cells, COLO 320 cells, L02 cells, mouse liver tissue, rat liver tissue, PC-3 cells |
| Positive IP detected in | HeLa cells |
| Positive IF/ICC detected in | PC-3 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
12235-1-AP targets NR4A1 in WB, IHC, IF/ICC, IP, CoIP, ChIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2875 Product name: Recombinant human NR4A1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 300-598 aa of BC016147 Sequence: KYICLANKDCPVDKRRRNRCQFCRFQKCLAVGMVKEVVRTDSLKGRRGRLPSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPF Predict reactive species |
| Full Name | nuclear receptor subfamily 4, group A, member 1 |
| Calculated Molecular Weight | 598 aa, 64 kDa |
| Observed Molecular Weight | 64-70 kDa |
| GenBank Accession Number | BC016147 |
| Gene Symbol | NR4A1 |
| Gene ID (NCBI) | 3164 |
| RRID | AB_10644125 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P22736 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
NR4A1 is an orphan nuclear receptor that act concomitantly with NURR1 in regulating the expression of delay-early genes during liver regeneration. Also NR4A1 has linked not only to cell apoptosis but also proliferation in response to growth factor. It plays a role in caspase-independent cell death by activation of the ERK pathway and increased activity of MEF2 transcription factors. NR4A1 exists some isoforms with MW 65 and 34 kDa.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for NR4A1 antibody 12235-1-AP | Download protocol |
| IP protocol for NR4A1 antibody 12235-1-AP | Download protocol |
| WB protocol for NR4A1 antibody 12235-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The NR4A1 Polyclonal antibody (catalog number 12235-1-AP) has 64 citations. These appear across journals including Nature Metabolism, Experimental & Molecular Medicine, Journal of Advanced Research, Advanced Science, Cell Death & Disease, Cell Reports, Brain, Behavior, and Immunity, Journal of Biological Chemistry, and Scientific Reports. Research fields span oncology (breast, lung, liver, glioma, melanoma), liver fibrosis and metabolic disease, neurodegeneration and epilepsy, inflammation and immunity, ferroptosis, and diabetes/glucose homeostasis, with applications in WB, IF, IHC, ChIP, and CoIP.
| Species | Application | Title |
|---|---|---|
Nat Metab HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma
| ||
Exp Mol Med NR4A1 suppresses breast cancer growth by repressing c-Fos-mediated lipid and redox dyshomeostasis | ||
J Adv Res Nur77 attenuates Paneth cell necroptosis-induced intestinal inflammation through regulating endoplasmic reticulum homeostasis in sepsis | ||
J Adv Res SLC7A11 as a therapeutic target to attenuate phthalates-driven testosterone level decline in mice. | ||
J Nanobiotechnology Enhancing antitumor immunity in triple-negative breast cancer through reversal of T-cell exhaustion using a CD8-targeted and membrane-camouflaged nanocarrier delivering small interfering RNA against sorting Nexin 9. | ||
Adv Sci (Weinh) A Graphene Composite Film Based Wearable Far-Infrared Therapy Apparatus (GRAFT) for Effective Prevention of Postoperative Peritoneal Adhesion |







